MYGN : Analysis & Opinions

  1. Are Short Sellers Wrong About These 3 Stocks?

    February 13, 2014
    Professional short sellers often like to work alone -- at least until they've built a sizable short position in a stock. ...
  2. Earn Up To 36% As Gold Rebounds With This Income Strategy

    February 13, 2014
    It's been more than two years since gold prices peaked. Since then, precious metal prices have been in a well-defined ...
  3. 13 Stock Buyback Kings: Should You Buy Them?

    February 12, 2014
    Over the past few years, I've been conducting quarterly reviews of companies that are aggressive repurchasers of their ...
  4. TMO Launches R&D Facility in China - Analyst Blog

    June 26, 2013
    Thermo Fisher recently launched its $9.5 million China Innovation Center in Shanghai.
  5. DaVita Partners Cureatr - Analyst Blog

    June 26, 2013
    DaVita HealthCare Partners Inc. entered into a strategic alliance with Cureatr
  6. Another Strategic Liaison for Myriad - Analyst Blog

    June 26, 2013
    Myriad inks agreement with TESARO to focus on companion diagnostics business.
  7. DGX Closes Dignity Health Acquisition - Analyst Blog

    June 25, 2013
    Quest Diagnostics recently completed the acquisition of lab-related clinical outreach service operations of Calif-based Dignity ...
  8. LH Partners Mitsubishi Chemical Med - Analyst Blog

    June 24, 2013
    Laboratory Corporation of America Holdings recently formed an alliance with Mitsubishi Chemical Medience Corporation.
  9. SNN's New Alliance for IV3000 Range - Analyst Blog

    June 20, 2013
    Smith & Nephew partners United Drug Medical to promote IV3000 line.
  10. LIFE Expands in China with Ribo - Analyst Blog

    June 20, 2013
    Recently Life Technologies came up with a new licensing agreement with Kunshan, China-based Suzhou Ribo Life Sciences Co. ...
  11. Abiomed Slips to Neutral - Analyst Blog

    June 20, 2013
    We downgraded Abiomed to Neutral, as we believe that the positives from its last earnings have already been factored into ...
  12. DaVita and Myriad Join Forces - Analyst Blog

    June 18, 2013
    DaVita HealthCare entered into a strategic liaison with Myriad Genetics.
  13. German Court Rules in Favor of MDT - Analyst Blog

    June 17, 2013
    Recently, Medtronic won a patent infringement case over its peer Edwards LifeSciences.
  14. Myriad: End to Legal Battle over Patents - Analyst Blog

    June 17, 2013
    Supreme Court reveals decision on Myriad's patent claims.
  15. LIFE Continues Korean Expansion - Analyst Blog

    June 14, 2013
    Life Technologies recently acquired a South Korea-based distributor, Life Science Korea.
  16. SGEN Starts Adcetris Phase I/II Study - Analyst Blog

    June 11, 2013
    Seattle Genetics commenced a phase I/II study to evaluate Adcetris in combination with Teva Pharma's Treanda (bendamustine) ...
  17. Life Expands Portfolio - Analyst Blog

    June 11, 2013
    Life introduces its Oncomine Next Gen Sequencing Power Tools.
  18. Quest Scans 2Q; Maintains FY13 View - Analyst Blog

    June 10, 2013
    Quest Diagnostics reaffirms outlook for 2013, discusses current environment for growth.
  19. Edwards Lowered to Underperform - Analyst Blog

    June 10, 2013
    We downgrade our recommendation on Edwards to Underperform.
  20. Qiagen Seeks FDA Approval - Analyst Blog

    January 18, 2013
    Qiagen NV (QGEN), a key provider of innovative technologies and products for pre-analytical sample preparation and molecular ...
  21. Qiagen Beats 2012 Placement Target - Analyst Blog

    January 15, 2013
    Qiagen (QGEN), a major provider of innovative technologies and products for pre-analytical sample preparation and molecular ...
  22. Biogen Idec and More Big Movers in Healthcare on January 3, 2 ...

    January 3, 2013
    This morning, the market has been relatively quiet. The Nasdaq remains relatively unchanged; the S&P 500 is unchanged; and ...
  23. Intuitive Surgical: A Strong Buy - Analyst Blog

    January 2, 2013
    Rising earnings estimates on the back of strong third quarter results - including a 28.2% earnings surprise - helped Intuitive ...
  24. Myriad Alleviates to Outperform - Analyst Blog

    December 21, 2012
    Following a strong first quarter result and an encouraging guidance, we upgrade our recommendation on Myriad Genetics (MYGN), ...
  25. Myriad Teams Up with Sanofi - Analyst Blog

    December 11, 2012
    Myriad RBM, a wholly-owned subsidiary of molecular diagnostic company Myriad Genetics Inc. (MYGN), has recently collaborated ...
  26. Medivation and Other Big Movers In Healthcare on December 3, ...

    December 3, 2012
    After the morning's trading, the Nasdaq is up 0.2%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2%. The healthcare ...
  27. United and More Big Movers in Healthcare on November 28, 2012

    November 28, 2012
    Currently, the Nasdaq has remained steady, the S&P 500 has increased 0.1% and the Dow is up 0.2%. The healthcare sector is ...
  28. Novo Nordisk A/S and More Big Movers in Healthcare on November ...

    November 6, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. The healthcare ...
  29. Myriad Remains Neutral - Analyst Blog

    September 21, 2012
    We have reaffirmed our Neutral recommendation on Myriad Genetics (MYGN) with a target price of $29.00. The company reported ...
  30. Cepheid Remains Neutral - Analyst Blog

    August 22, 2012
    We recently reiterated our Neutral recommendation on Cepheid (CPHD) with a target price of $38.00. The company reported ...
  31. St Jude Medical and Other Big Movers In Healthcare

    August 16, 2012
    The Nasdaq is trading up 0.8%, the S&P 500 has moved up 0.3% and the Dow has increased 0.3%, marking a bad morning for the ...
  32. FDA Approves Qiagen's KRAS Test - Analyst Blog

    July 9, 2012
    Molecular diagnostics solutions provider, Qiagen (QGEN) recently got the nod of the U.S. Food and Drug Administration ("FDA") ...
  33. Genomic Health to Outperform - Analyst Blog

    July 6, 2012
    We recently upgraded Genomic Health (GHDX) to 'Outperform' from 'Neutral' on the basis of robust growth in its Oncotype DX ...
  34. Medicine Gets Personalized

    June 28, 2012
    With our population continuing to age and grow, innovation in the healthcare sector will need to move just as fast. One such ...
  35. Myriad Beats, Raises Guidance - Analyst Blog

    May 2, 2012
    Myriad Beats, Raises Guidance - Analyst Blog
  36. Biotech Trends: Analysts Expect Big Growth for Genetic Testing ...

    March 13, 2012
    Analysts expect genetic testing to bring in $15 - $25 billion per year for the next decade, with an expected annual growth ...
  37. The Stock-Split Portfolio

    December 6, 2010
    Many investors debate the merits of a stock split, but the bottom line doesn't lie. Find out how companies who split their ...
  38. Five Mid Caps The Pros Own

    September 17, 2009
    We look at what stocks the most successful mid-cap funds have in common.
  39. High-Risk Acquisition The Right Prescription For Pfizer?

    September 5, 2008
    Pfizer needs to refresh its pipeline, but taking on a high-risk/high-reward experimental drug could do more harm than good.
  40. Time For A Diagnostics Test (VIVO, CYTC, MYGN)

    October 4, 2007
    Put the million-dollar research of a biotech ETF to work for you - for free.
Investing News
  1. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  2. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  3. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  4. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  5. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
  6. Can Paying Off Your Mortgage Early Hurt Your Net Worth?

    Saving your money and making double or even triple payments on a mortgage may sound productive, ...
Trading Center